Increased levels of the YKL-40 protein have been found in patients with a broad spectrum of pathologies, including those with rheumatoid arthritis [13], obstructive sleep apnea syndrome [24], solid malignancies [25], atherosclerosis [26], and diabetes mellitus [27, 28]. This evidence concerns the gene CHI3L1 and atherosclerosis.